abstract |
FIELD: pharmaceuticals. n SUBSTANCE: claimed method relates to application of DNA oligonucleotide useful in inhibition of STAT-1 transcription factor to produce drug for amelioration of inflammation reactions and preventing and/or therapy of ishemic/reperfusion damages in surgery and organ transplantation, respectively. n EFFECT: therapy of increased effectiveness. n 9 ex, 10 dwg |